UROVANT SCIENCES
LIVE

Serial Number

79331299

Owner

Urovant Sciences GmbH

Attorney

Jeffrey R. Cadwell

Filing Date

Oct 26, 2021

Add to watchlist:

No watchlists yet
View on USPTO

UROVANT SCIENCES Trademark

Serial Number: 79331299 • Registration: 6938285

UROVANT SCIENCES is a trademark filed by Urovant Sciences GmbH on October 26, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 38 (Telecommunications), Class 41 (Education & Entertainment), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Urovant Sciences GmbH (20 trademarks)

Gotthardstrasse 3

Entity Type: 99

Trademark Details

Filing Date

October 26, 2021

Registration Date

January 3, 2023

Published for Opposition

October 18, 2022

Goods & Services

Providing educational information in the academic fields relating to prevention, identification and treatment of diseases related to medical conditions, as well as urological, metabolic, urinary tract system, bladder and reproductive organ pathologies, disorders and diseases for the purpose of academic study; providing educational information in the academic fields of biological and pharmaceutical preparations for the prevention of medical conditions, as well as urological, metabolic, urinary tract system, bladder and reproductive organ pathologies, disorders and diseases for the purpose of academic study; providing educational information in the fields of prevention, identification and treatment of medical conditions, as well as urological, metabolic, urinary tract system, bladder and reproductive organ pathologies, disorders and diseases for medical purposes; educational and entertainment services, namely, providing motivational and educational speakers in the fields of medicine, health, pharmaceuticals, and disease and disorder identification, treatment and prevention; providing online non-downloadable articles in the fields of medicine, health, pharmaceuticals and disease and disorder identification, treatment and prevention

Providing online chat rooms for transmission of messages among computer users concerning disease prevention, identification and treatment education relating to medical conditions, as well as urological, metabolic, urinary tract system, bladder and reproductive organ pathologies, disorders and diseases; peer-to-peer network computer services, namely, electronic transmission of audio sequences, video sequences as well as other data and documents among computers, such audio sequences, video sequences and other data and documents all relating to prevention, identification and treatment of medical conditions, as well as urological, metabolic, urinary tract system, bladder and reproductive organ pathologies, disorders and diseases; providing online chat rooms for transmission of messages among computer users concerning the fields of biological and pharmaceutical preparations; peer-to-peer network computer services, namely, electronic transmission of audio sequences, video sequences as well as other data and documents among computers, such audio sequences, video sequences and other data and documents all relating to the fields of biological and pharmaceutical preparations

Pharmaceutical and biological preparations, for the prevention of urological, urinary tract systems, and reproductive organ diseases and disorders; pharmaceutical preparations for human use for the prevention of urological, urinary tract systems, and reproductive organ diseases and disorders; biological and pharmaceutical preparations for medical and therapeutic use for the prevention of urological, urinary tract systems, and reproductive organ diseases and disorders; pharmaceutical preparations for human use for the prevention of medical conditions, namely, urological, urinary tract system and reproductive organ disorders; pharmaceutical preparations for human use for the treatment of medical conditions, namely, urological, urinary tract system and reproductive organ disorders; biological and pharmaceutical preparations for medical and therapeutic use for the prevention of medical conditions, namely, urological, urinary tract system and reproductive organ disorders; biological and pharmaceutical preparations for medical and therapeutic use for the treatment of medical conditions, namely, urological, urinary tract system and reproductive organ disorders

Provision of health information and medical information, all for treatment and diagnostic purposes; provision of information concerning the diagnostic, prophylactic and therapeutic properties of pharmaceutical and biological preparations for prevention and treatment of diseases, conditions, disorders and pathologies; providing health care advice and medical advice in the fields of prevention, identification and treatment of medical conditions, as well as urological, metabolic, urinary tract system, bladder and reproductive organ pathologies, disorders and diseases; providing medical and physical health advice in the fields of biological and pharmaceutical preparations for medical use

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Mar 13, 2025 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 3, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 3, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 3, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 3, 2024 REAP
WITHDRAWAL OF ATTORNEY GRANTED
Apr 12, 2024 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Apr 12, 2024 WOAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 8, 2024 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Apr 8, 2024 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 8, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 8, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 8, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 8, 2024 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Feb 23, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 17, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 20, 2023 FICS
FINAL DISPOSITION PROCESSED
Apr 20, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 3, 2023 FICR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 18, 2023 ADCH
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 3, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 3, 2023 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
Nov 25, 2022 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 18, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 18, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 28, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 12, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 1, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 31, 2022 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Apr 30, 2022 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Apr 30, 2022 NREP
REFUSAL PROCESSED BY IB
Apr 18, 2022 RFNT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 28, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 28, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 28, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 28, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 28, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 28, 2022 COAR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 25, 2022 RFCS
REFUSAL PROCESSED BY MPU
Mar 25, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 19, 2022 RFCR
NON-FINAL ACTION WRITTEN
Feb 18, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 11, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 25, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 21, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 20, 2022 REPR